Treatment of Clostridium difficile infection using SQ641, a capuramycin analogue, increases post-treatment survival and improves clinical measures of disease in a murine model

OBJECTIVES: Clostridium difficile infection (CDI) is a primary cause of antibiotic-associated diarrhoeal illness. Current therapies are insufficient as relapse rates following antibiotic treatment range from 25% for initial treatment to 60% for treatment of recurrence. In this study, we looked at th...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Antimicrob Chemother
Prif Awduron: Moore, John H., van Opstal, Edward, Kolling, Glynis L., Shin, Jae Hyun, Bogatcheva, Elena, Nikonenko, Boris, Einck, Leo, Phipps, Andrew J., Guerrant, Richard L., Protopopova, Marina, Warren, Cirle Alcantara
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2016
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4830414/
https://ncbi.nlm.nih.gov/pubmed/26832756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkv479
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg